Cabaletta Bio (CABA) announced recent pipeline and operational progress and outlined its strategic priorities and anticipated key milestones ...

In a report released today, Sami Corwin from William Blair maintained a Buy rating on Cabaletta Bio (CABA – Research Report). The company’s ...

The attorney will be sworn in at CABA’s 51st annual installation gala on Saturday, Feb. 8, at the Intercontinental Hotel in ...

Cabaletta Bio’s financials and CAR T-cell therapy show potential but face risks. Discover why CABA stock is a risky yet ...

Their top prospect, Andrew Painter, is knocking on the door of finally making his Major League debut. That goes right in line ...

The Phillies avoided salary arbitration with left-hander Jesus Luzardo by reportedly reaching a one-year contract ahead of ...

Investing.com – U.S. stocks were lower after the close on Tuesday, as losses in the Technology, Industrials and Utilities sectors led shares lower. At the close in NYSE, the Dow ...

In November 2024, Cabaletta presented new and updated clinical data on rese-cel supporting its potential to achieve drug-free ...